Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

Rosario, D.J. orcid.org/0000-0002-9086-3592 and Bourke, L. (2013) Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness? British Journal of Cancer, 108 (10). p. 2194. ISSN 1532-1827

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2013 Cancer Research UK. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Dates:
  • Published: 28 May 2013
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 05 Dec 2016 14:43
Last Modified: 05 Dec 2016 14:49
Published Version: http://dx.doi.org/10.1038/bjc.2013.211
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/bjc.2013.211
Related URLs:

Share / Export

Statistics